Danaher Corporation (DHR) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Washington, DC, United States. Der aktuelle CEO ist Rainer Blair.
DHR hat IPO-Datum 1978-12-29, 61,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $140.44B.
Danaher Corporation is a global manufacturer of professional, medical, industrial, and commercial products and services headquartered in Washington, D.C. The company operates three primary business segments: Life Sciences, which provides mass spectrometers, flow cytometry, genomics, lab automation, and bioprocess technologies serving pharmaceutical, biopharmaceutical, and research institutions; Diagnostics, which offers clinical chemistry, immunoassay, hematology, and molecular diagnostic systems for hospitals and laboratories; and Environmental & Applied Solutions, which provides water analysis and treatment instrumentation alongside color management and product packaging solutions. With a diversified portfolio spanning life sciences research, clinical diagnostics, and environmental monitoring, Danaher serves customers across healthcare, pharmaceutical, food and beverage, and industrial sectors worldwide. Founded in 1969, the company has established itself as a leader in analytical and diagnostic technologies.
